IL17A and benign prostatic hyperplasia: A more detailed study investigated the expression of a wide spectrum of IL-17 types and their receptors with a comparison between normal prostate, PCa, and BPH tissues, demonstrating that IL-17A, acting through the IL-17RA receptor, may contribute to the development of PCa and BPH.